Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503

Source :: PR Newswire. April 10, 2024
Publication Year :: 2024
Abstract: HOLON, Israel, April 10, 2024 /PRNewswire/ -- http://www.cgen.com/(NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the simultaneous online publication of [...]

Subjects :: Gilead Sciences Inc.
Compugen Ltd.
Biological products industry -- Health aspects
Oncology, Experimental -- Health aspects
Protein binding -- Health aspects
Biotechnology industry -- Health aspects
Viral antibodies -- Health aspects
Cancer -- Health aspects -- Research
Antibodies -- Health aspects
Business
News, opinion and commentary

Tools